Structural Biology – Products

NanoImaging Services, Inc. has announced the opening of a new facility to support its growing customer base requiring cryoEM for drug discovery and vaccine development applications. COVID-19 projects are receiving prioritization.

The companies have teamed up to promote the use of protein footprinting technologies, products, and contract research services in biopharmaceutical research and development.

A multi-million-pound high-performance computer (HPC) at the University of Hull is playing a crucial role in global COVID-19 research.

OXGENE™ and The Native Antigen Company have announced a collaboration to scale up their antigen manufacturing capabilities to deliver high-purity, recombinant proteins for the development of diagnostics and vaccines.

The Native Antigen Company has announced the commercial introduction of its Novel Coronavirus antigens, derived from the emerging Wuhan strain.

Fluidic Analytics Ltd has launched fluidiphore rapid amine 503, a protein labeling kit designed to be time-saving and affordable.

Fluidic Analytics Ltd will attend a number of events this Autumn to showcase its technology for studying protein interactions.

Bruker and its scientific collaborators are presenting 1.2 GHz high-resolution NMR data that has been acquired using a new 1.2 GHz 3 mm triple-inverse TCI CryoProbe.

Developed to enable the reliable, consistent and scalable application of cryo-electron microscopy to protein research and drug discovery.

FEBS/EMBO Women in Science Award Lecture highlights Fluidic Analytics’ diffusional sizing technology as key technique for confidently analysing difficult-to-study proteins in-solution.